The challenge of vaccine hesitancy in the European Union

Similar documents
Conclusions of the high level hearing on seasonal influenza 30 April 2015, Luxembourg Michael Sulzner

Updates from the European Centre for Disease Prevention and Control

Opinion. Vaccination Programmes and Health Systems in the EU. Expert Panel on Effective Ways of Investing in Health

LIFE-COURSE IMMUNISATION

Vaccine shortages: Improving cooperation, communication and management Michael Sulzner

Action Plan on HIV/AIDS in the EU and neighbouring countries:

Addressing Complacency, Convenience and Confidence

Vaccine confidence in Europe: time for action

The Life Course Immunisation Initiative

Understanding vaccine hesitancy in a post-factual era

14152/1/18 REV 1 LES/ads LIFE.2.C. Brussels, 20 November 2018 (OR. en) 14152/1/18 REV 1. Interinstitutional File: 2018/0115(NLE)

Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU

From package to protection - how do we close global coverage gaps to optimise the impact of vaccination?

GAVI S CONTINUED ROLE IN YELLOW FEVER CONTROL

10.4 Advocacy, Communication and Social Mobilization Working Group: summary strategic plan,

Pandemic (H1N1) 2009 influenza vaccination in the EU

Proposal for an EU Joint Action on Vaccination: Cross-border challenges to be addressed

TELL ME Communication Kit

ELECTRONIC IMMUNISATION RECORD

15571/17 YML/ik 1 DG C 1

Schmallenberg virus: Risk Management and Control Strategy in the EU

Consultation on Strengthened EU cooperation against vaccine preventable diseases

PREVENTION FIRST : VACCINATION AT THE HEART OF PUBLIC HEALTH

Moving towards 2020 priorities for Public Health for the years Health and Consumers

Vaccine hesitancy in the EU: state of play and impact on vaccination programmes

Peer counselling A new element in the ET2020 toolbox

Strategy and documentation of the measles and rubella elimination in the WHO Regional Office for Europe

COU CIL OF THE EUROPEA U IO. Brussels, 27 July /09 ADD 2 SA 202 SOC 459 RECH 237 COVER OTE

LOGFRAME TEMPLATE FOR SWAZILAND. SIDA s Contributions

The role of All-Ukrainian Network of PLWH in empowering the civil society. Think Tank meeting, Brussels, 2007

Ensuring the quality of polio outbreak response activities: A rationale and guide for 3 month, quarterly and 6 month independent assessments

Pandemic lessons learnt

Discovery and validation of novel. Webinar IMI2 - Call 9 Joint influenza vaccine effectiveness studies

Maltese Presidency of the Council of the European Union. Ministry for Health

REPRODUCTIVE, MATERNAL, NEWBORN AND CHILD HEALTH (RMNCH) GLOBAL AND REGIONAL INITIATIVES

Strategies to address vaccine hesitancy:

Current developments at EIGE for EU candidate and potential candidate countries

Pfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016

LOGFRAME TEMPLATE FOR MALAWI. Linking HIV and Sexual Reproductive Health and Rights in Southern Africa ( )

Multi-sectoral aspects of pandemic preparedness and response

ENDING HOMELESSNESS WHY WE NEED MORE SOCIAL INNOVATION AND INVESTMENT

Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe. Lucca, Italy March 2008

Draft resolution submitted by the President of the General Assembly

Public health dimension of the world drug problem

Viral Hepatitis Burden and Policy Directions in the European Region of WHO

1. The Working Party on Public Health discussed and agreed the draft Council conclusions as set out in the Annex.

The Maltese Presidency of the Council of the EU Veterinary Sector

COMMISSION DELEGATED REGULATION (EU) /... of XXX

COUNCIL OF THE EUROPEAN UNION. Brussels, 7 July /04 CORDROGUE 59

Economic and Social Council

Resolution adopted by the Human Rights Council on 30 September /18. Preventable maternal mortality and morbidity and human rights

Pogány Gábor Ph.D. President of HUFERDIS Member of EUCERD and Orphanet International Advisory Board

Midterm Review of the Global Measles and Rubella Strategic Plan W. A. Orenstein, MD SAGE Geneva, 19 October 2016

COMMISSION OF THE EUROPEAN COMMUNITIES

EFSA cross-cutting guidance lifecycle. European Food Safety Authority (EFSA), Daniela Maurici, Raquel Garcia Matas, Andrea Gervelmeyer

Summary Report EU Health Award 2017

COMMISSION DELEGATED REGULATION (EU) /... of XXX

can CAMPAIGN STRATEGY PAPER

ECDC s role in the fight against HIV/AIDS in Europe

An example of intersectoral collaboration: the EU model. European Commission Health and Consumers Directorate-General (DG SANCO)

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

DIRECTIVES. (Text with EEA relevance)

International Kidney Cancer Coalition. Patient Organisations Working Together Globally to Support Those Affected by Kidney Cancer

Council of the European Union Brussels, 27 March 2017 (OR. en)

Managing public concerns. Jo Yarwood Department of Health England

Resolution adopted by the General Assembly on 18 December [on the report of the Third Committee (A/69/481)]

Health Programme support to the European Action Plan HIV/AIDS

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY

ANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA

COUNCIL OF THE EUROPEAN UNION. Brussels, 8 May /07 SAN 89. NOTE from : Permanent Representatives Committee

Action plan for the health sector response to viral hepatitis in the WHO European Region

European Parliament Interest Group on Mental Health, Well-being and Brain Disorders

Cancer Research in the EU Framework Programmes for RTD

3135th JUSTICE and HOME AFFAIRS Council meeting Brussels, 13 and 14 December 2011

GAVI, THE VACCINE ALLIANCE

rare diseases research through National Plans and Strategies

Economic and Social Council

Changing the prevention paradigm for the future what Europe can do

Back to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office

Vaccine Hesitancy a widespread problem. Increasing vaccination uptake ECDC communication materials and pilot projects

ACP-EU JOINT PARLIAMENTARY ASSEMBLY Committee on Social Affairs and the Environment

Official Journal of the European Union

15050/15 JS/pm 1 DGB 3B

Vaccination glossary. Vaccine

Economic and Social Council

Public Health Programme : Information Day Work shop: Health Threats

Gavi Alliance Strategy : Goal level indicators and disease dashboard

Information resources for healthcare professionals on immunisation schedules and vaccines in EU countries

Impact of 5As Strategy on Vaccination Coverage against influenza in Mexico. Season

Council of the European Union Brussels, 28 October 2015 (OR. en)

APPROVAL PROCESS 1.0 Approved by: Joint GAVI Alliance & Fund Board

Legislative Approaches to Immunization Across the European Region

5163/18 GSC/ar 1 DGB 2B

Table Of Content. Annex 1: Conference report... 7 Annual project reports (URL)... 7 Original Full Information (Dec 2008)... 7.

Childhood Vaccination and Immunisation

Increasing the uptake of MMR in London: executive summary of findings from the social marketing project, November 2009

1.0 BACKGROUND / PROJECT DESCRIPTION

Council Recommendation on strengthened cooperation against vaccine preventable diseases. Factual report of the online public consultation

NORDIC CONFERENCE ON RARE DISEASES

Transcription:

The challenge of vaccine hesitancy in the European Union Michael Sulzner AIM SEMINAR Vaccine hesitancy, a global trend which threatens public health 11 December 2017, Brussels

Outline - Competence - Political context - Characteristics/challenges/requirements - Joint action on vaccination 2018 - Policy initiative on vaccination 2018

Vaccination is a competence of the Member States On the basis of Article 168 of the Treaty on the Functioning of the European Union the Commission is supporting Member States in encouraging their cooperation, while fully respecting national competences in the area of public health.

Council conclusions on vaccinations as an effective tool in public health Evidence-based, cost-effective, safe and efficient immunisation systems is an integral part of a wellfunctioning health system To inform the population in order to raise its trust in vaccination programmes, using appropriate tools and communication campaigns also by engaging opinion leaders, civil society and relevant stakeholders To coordinate activities aimed at advocating and encouraging the use of vaccines included in national vaccination programmes by sharing information on communication plans and campaigns for vaccine introduction

Characteristics of vaccine hesitancy Vaccine hesitancy is a behavioural phenomenon that is vaccine and context specific Vaccine attitudes are ranging from total acceptance to complete refusal Vaccine-hesitant individuals Are a heterogeneous group in the middle of this continuum May refuse some vaccines, but agree to others Delay vaccines or accept vaccines but are unsure in doing so

Challenges related to vaccine hesitancy Lack of validated and standarized tools to assess and measure hesitancy Lack of data on vaccine hesitancy levels in the populations where the interventions were tested Special attention needs to be paid to differences and similarities between routine immunisation programmes and mass vaccination campaigns in different settings and contexts Evaluation of interventions Most studies have not defined vaccine hesitancy in the study population and have only measured change in vaccine uptake, without assessing whether the intervention had any impact on hesitancy

Requirements Increase the understanding of vaccine hesitancy, its determinants and the rapidly changing challenges it entails Structures and organizational capacity to decrease hesitancy and increase acceptance of vaccines at all levels Sharing of lessons learnt and effective practices from various countries and settings Development, validation and implementation of new tools to address hesitancy

3 million EU co-funding Joint action on vaccination Coordination by INSERM (France) Participation of 20 countries (among them 17 EU MS) JA currently under preparation, starting early 2018 Involvement of ECDC, EMA, WHO, DG RTD

Joint action on vaccination Establish shared mapping of best practices among stakeholders and analyse barriers and enablers behind high and low vaccination coverage rates. Set-up social and online media monitoring infrastructures to conduct real time public vaccine confidence monitoring through social media. Provide guidance on the evaluation of the impact of intervention strategies to address vaccine hesitancy. Provide guidance and share best practice on the development and provision of in-service training for health professionals.

Joint action on vaccination Provide guidance and/or promote the exchange of best practices in the field of vaccine injury compensation programmes Assess and describe European vaccine reminder and recall systems to inform future development of such systems Integrate /link immunisation information systems into e-health network to Empower communication towards patients and health professionals to facilitate understandings of benefits of vaccination

EU policy initiative on vaccination President Juncker s State of the Union Address 2017 touching on ongoing large measles outbreaks in a number of countries Commission will present an initiative on vaccination in from of a Council recommendation as part of the Commission s Work Programme 2018 Roadmap on "Strengthened cooperation against vaccine preventable diseases" Public consultation

Commission Use vaccines as the case study for combatting fake news in the EU Possible initiative regarding EU-wide advocacy coalition

Thank you for your attention Commission web page on vaccination: http://ec.europa.eu/health/vaccination/policy/index_en.htm Conference web page: http://ec.europa.eu/health/vaccination/events/ev_20121016_en.htm